REFERENCES
B. Kari. Control of blood glucose levels in alloxan-diabetic rabbits by iontophoresis of insulin. Diabetes 35:217–221 (1986).
K. Fellinger and J. Schmid. Klinik und therapie des chronischen gelenhuematismus. Wein 549–552 (1954).
J. E. Griffin, J. L. Echternach, R. E. Price, and J. C. Touchstone. Patients treated with ultrasonic driven hydrocortisone and with ultrasound alone. Phys. Ther. 47:594–601 (1967).
J. C. McElnay, T. A. Kennedy, and R. Harland. The influence of ultrasound on the percutaneous absorption of fluocinolone acetonide. Int. J. Pharm. 40:105–110 (1987).
H. Benson, J. C. McElnay, J. Whiteman, and R. Harland. Lack of effect of ultrasound on the percutaneous absorption of benzydamine. J. Pharm. Pharmacol. 38S:73P (1986).
H. Benson, J. McEnlay, and R. Harland. Use of ultrasound to enhance percutaneous absorption of benzydamine. Phys. Ther. 69:113–118 (1989).
D. Levy, J. Kost, Y. Meshulam, and R. Langer. Effect of ultrasound on transdermal drug delivery to rats and guinea pigs. J. Clin. Invest. 83:2074–2078 (1989).
R. Brucks, M. Navavaty, D. Jung, and F. Siegel. The effect of ultrasound on in vitro penetration of ibuprofen through human epidermis. Pharm. Res. 6:697–701 (1989).
K. Tachibana and S. Tachibana. Transdermal delivery of insulin by ultrasonic vibration. J. Pharm. Pharmacol. 43:270–271 (1991).
K. Tachibana and S. Tachibana. Usage of ultrasonic vibration as a new transdermal insulin delivery system. Diab. Res. Clin. Pract. 1–5 (Suppl.):S166 (1988).
P. Tyle and P. Agrawala. Drug delivery by phonophoresis. Pharm. Res. 6:355–361 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tachibana, K. Transdermal Delivery of Insulin to Alloxan-Diabetic Rabbits by Ultrasound Exposure. Pharm Res 9, 952–954 (1992). https://doi.org/10.1023/A:1015869420159
Issue Date:
DOI: https://doi.org/10.1023/A:1015869420159